These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22229574)

  • 21. Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management.
    Parkins MD; Elborn JS
    J Antimicrob Chemother; 2010 Sep; 65(9):1853-61. PubMed ID: 20605846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients.
    Spicuzza L; Sciuto C; Vitaliti G; Di Dio G; Leonardi S; La Rosa M
    Eur J Clin Microbiol Infect Dis; 2009 Feb; 28(2):191-5. PubMed ID: 18758832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis.
    Fusco NM; Toussaint KA; Prescott WA
    Ann Pharmacother; 2015 Apr; 49(4):458-68. PubMed ID: 25583881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current microbiological data on lower respiratory tract infection in cystic fibrosis. Part I: Isolated microorganisms and their clinical significance].
    Coman G; Petraru E; Dahorea C; Anton DT
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):580-7. PubMed ID: 23077957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
    BMC Pulm Med; 2017 Jul; 17(1):106. PubMed ID: 28750627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging cystic fibrosis pathogens and the microbiome.
    Mahenthiralingam E
    Paediatr Respir Rev; 2014 Jun; 15 Suppl 1():13-5. PubMed ID: 24832700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does Cefiderocol Have a Potential Role in Cystic Fibrosis Pulmonary Exacerbation Management?
    Gavioli EM; Guardado N; Haniff F; Deiab N; Vider E
    Microb Drug Resist; 2021 Dec; 27(12):1726-1732. PubMed ID: 34077286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unusual respiratory bacterial flora in cystic fibrosis: microbiologic and clinical features.
    Beringer PM; Appleman MD
    Curr Opin Pulm Med; 2000 Nov; 6(6):545-50. PubMed ID: 11100967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiology of airway disease in a cohort of patients with cystic fibrosis.
    Lambiase A; Raia V; Del Pezzo M; Sepe A; Carnovale V; Rossano F
    BMC Infect Dis; 2006 Jan; 6():4. PubMed ID: 16405721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria.
    Hadjiliadis D; Steele MP; Chaparro C; Singer LG; Waddell TK; Hutcheon MA; Davis RD; Tullis DE; Palmer SM; Keshavjee S
    J Heart Lung Transplant; 2007 Aug; 26(8):834-8. PubMed ID: 17692788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation of pulmonary bacterial pathogens in cystic fibrosis by volatile metabolites emitted by their in vitro cultures: Pseudomonas aeruginosa, Staphylococcus aureus, Stenotrophomonas maltophilia and the Burkholderia cepacia complex.
    Dryahina K; Sovová K; Nemec A; Španěl P
    J Breath Res; 2016 Aug; 10(3):037102. PubMed ID: 27506232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibility of microorganisms isolated from sputum culture of patients with cystic fibrosis: Methicillin-resistant Staphylococcus aureus as a serious concern.
    Mazloomi Nobandegani N; Mahmoudi S; Pourakbari B; Hosseinpour Sadeghi R; Najafi Sani M; Farahmand F; Motamed F; Nabavizadeh Rafsanjani R; Mamishi S
    Microb Pathog; 2016 Nov; 100():201-204. PubMed ID: 27666507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled Antibiotic Therapy in Chronic Respiratory Diseases.
    Maselli DJ; Keyt H; Restrepo MI
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28509852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bacterial infections and resistance to antibiotics in cystic fibrosis].
    Taccetti G; Repetto T; Procopio E; Marianelli L; Campana S
    Pediatr Med Chir; 1999; 21(5 Suppl):213-8. PubMed ID: 10963010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cell division protein FtsZ as a cellular target to hit cystic fibrosis pathogens.
    Buroni S; Makarov V; Scoffone VC; Trespidi G; Riccardi G; Chiarelli LR
    Eur J Med Chem; 2020 Mar; 190():112132. PubMed ID: 32066012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in the microbiology of respiratory tract infection in cystic fibrosis.
    Foweraker J
    Br Med Bull; 2009; 89(1):93-110. PubMed ID: 19155262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005.
    Razvi S; Quittell L; Sewall A; Quinton H; Marshall B; Saiman L
    Chest; 2009 Dec; 136(6):1554-1560. PubMed ID: 19505987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging cystic fibrosis pathogens: incidence and antimicrobial resistance.
    Magni A; Giordano A; Mancini C; Pecoraro C; Varesi P; Quattrucci S; Trancassini M
    New Microbiol; 2007 Jan; 30(1):59-62. PubMed ID: 17319602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
    Aanæs K
    J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cystic fibrosis lung microbiome.
    Surette MG
    Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S61-5. PubMed ID: 24437409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.